Tuesday 25th January 2022 |
Text too small? |
Green Cross Health (NZX: GXH ) is currently experiencing higher than anticipated revenue and profitability relative to the prior period. For the 9 months to 31 December 2021, the company has experienced an increase in revenue of approximately 14%.
Group CEO Rachael Newfield said “This uplift is primarily the result of increased COVID-19 related activity across the company’s three divisions of Medical, Pharmacy and Community Health as well as the impact of recent acquisitions in the Medical division. The company notes that this uplift may not continue in full into the next financial year due to the uncertain and changeable outlook for COVID-19 vaccination and swabbing activity”.
Whilst Omicron has introduced further uncertainty, Net Profit After Tax Attributable to Shareholders for the 12 months to 31 March 2022 is projected to exceed the prior period result by $4.5m - $6.5m. Green Cross Health is scheduled to release its audited full year result for the year to 31 March 2022 on 27 May 2022.
Please see the link below for details
Source: Green Cross Health Limited
No comments yet
ikeGPS Chief Financial Officer Transition
TWL - TradeWindow announces strategic partnership with FTA
BLT - Patent issue settled and new 5 year agreement with BSP
July 2nd Morning Report
July 1st Morning Report
June 27th Morning Report
SDL - FY2026 Earnings Guidance
PaySauce Director resigns for US-based role with NZTE
General Capital Releases 2025 Annual Report
June 26th Morning Report